Our in vivo and in vitro studies support that, in the context of breast cancer, senescent osteocytes have increased osteoclastogenic potential (increased Rankl, Mmp13, Il6) and are key drivers of cancer-induced bone resorption. This evidence concerns the gene IL6 and breast cancer.